CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,299 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05792618
NCT05792618N/ACompleted

Stroke Patients and Family in Rural China: A Longitudinal Study in Hebei Province

Duke Kunshan University·observational·Posted Mar 31, 2023·Updated Jun 10, 2024

In Brief

An observational study for Stroke. Completed, enrolled 1,299 participants across 1 site.

Detailed Summary

SaFaRI is a large prospective cohort study in Hebei Province, rural Northern China including 1,299 stroke patients and their spouses. Follow-up visits take place from baseline until the fifth year after the baseline survey, investigating the lifestyle and health behavior, disease history, medication and adherence to medication, health status and self-reported health, cognitive function, and medication cost. As additional measures, the investigators will collect information on hospitalization, recurrence, and vital status from county medical insurance system and death record system. Patients will also have a physical examination comprising of assessment of blood pressure, weight, height, waist circumference, neck circumference, grip strength and the "Timed Up and Go" test.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesChina

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 31, 2023
Enrollment StartSep 1, 2022
Primary CompletionJun 1, 2023
Study CompletionJun 1, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.3 years ago